TY  - GEN
AU  - Fleming,Gini F
AU  - Filiaci,Virginia L
AU  - Marzullo,Brandon
AU  - Zaino,Richard J
AU  - Davidson,Susan A
AU  - Pearl,Michael
AU  - Makker,Vicky
AU  - Burke,James J
AU  - Zweizig,Susan L
AU  - Van Le,Linda
AU  - Hanjani,Parviz
AU  - Downey,Gordon
AU  - Walker,Joan L
AU  - Reyes,Henry D
AU  - Leslie,Kimberly K
TI  - Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study
SN  - 1095-6859
PY  - 2014///0428
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Disease-Free Survival
KW  - Drug Administration Schedule
KW  - Endometrial Neoplasms
KW  - drug therapy
KW  - Female
KW  - Humans
KW  - Immunohistochemistry
KW  - Megestrol Acetate
KW  - administration & dosage
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Neoplasm Recurrence, Local
KW  - Sirolimus
KW  - Tamoxifen
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1016/j.ygyno.2014.01.015
ER  -